JNJ vs REGN
By Alex · Tickerpine
Johnson & Johnson vs Regeneron Pharmaceuticals, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | REGN |
|---|---|---|
| Price | $285.75 | $955.47 |
| Market cap | $687.89B | $98.84B |
| P/E ratio | 43.4 | 21.1 |
| ROE | 20.02% | 14.95% |
| Profit margin | 16.20% | 28.51% |
| Revenue growth | 5.90% | 36.30% |
| Dividend yield | 1.88% | 0.39% |
| Beta | 0.20 | 0.10 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs REGN in plain English
- JNJ is the bigger company — about 7.0× the market cap of REGN.
- REGN is cheaper on earnings (P/E 21.1 vs 43.4).
- JNJ earns a higher return on equity (20% vs 15%).
- REGN is growing revenue faster (36% vs 6%).
- JNJ has the higher dividend yield (1.88% vs 0.39%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
REGN return calculator
See what $1,000 in Regeneron Pharmaceuticals, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.